Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Debt Ratio: 2018-2024

Historic Debt Ratio for Akebia Therapeutics (AKBA) over the last 7 years, with Dec 2024 value amounting to 0.18.

  • Akebia Therapeutics' Debt Ratio fell 29.34% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year decrease of 29.34%. This contributed to the annual value of 0.18 for FY2024, which is 22.20% up from last year.
  • As of FY2024, Akebia Therapeutics' Debt Ratio stood at 0.18, which was up 22.20% from 0.14 recorded in FY2023.
  • In the past 5 years, Akebia Therapeutics' Debt Ratio registered a high of 0.19 during FY2022, and its lowest value of 0.14 during FY2023.
  • For the 3-year period, Akebia Therapeutics' Debt Ratio averaged around 0.17, with its median value being 0.18 (2024).
  • As far as peak fluctuations go, Akebia Therapeutics' Debt Ratio spiked by 52.22% in 2020, and later dropped by 22.68% in 2023.
  • Over the past 5 years, Akebia Therapeutics' Debt Ratio (Yearly) stood at 0.15 in 2020, then grew by 23.16% to 0.18 in 2021, then increased by 0.71% to 0.19 in 2022, then decreased by 22.68% to 0.14 in 2023, then grew by 22.20% to 0.18 in 2024.